Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1968032 | Clinica Chimica Acta | 2006 | 6 Pages |
Abstract
Pioglitazone inhibited the upregulation of LOX-1 on HUVECs elicited by oxLDL and subsequently decreased HUVECs CD40/CD40L expression induced by oxLDL. These observations provided novel insight into a potential novel anti-inflammatory pathway of thiazolidinediones.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
De-qian Jiang, Luo-xiang Chu, Zhao-yun Liu, Shun-bao Zhang,